Home
About
Overview
Sharing Data
ORCID
Help
History (19)
p53RDL1 regulates p53-dependent apoptosis.
ILM peeling a vital intervention for many vitreoretinal disorders.
Chimerism after organ transplantation.
National Analysis of State Health Policies on Students' Right to Self-Carry and Self-Administer Asthma Inhalers at School.
Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Gordon, Kenneth
One or more keywords matched the following items that are connected to
Gordon, Kenneth
Item Type
Name
Concept
Tumor Necrosis Factor-alpha
Concept
Receptors, Tumor Necrosis Factor
Academic Article
Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.
Academic Article
Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.
Academic Article
A randomized trial of etanercept as monotherapy for psoriasis.
Academic Article
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
Academic Article
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
Academic Article
Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation.
Academic Article
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
Academic Article
Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation.
Academic Article
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Academic Article
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Academic Article
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article
Strategies for treatment with anti-tumor necrosis factor agents in psoriasis: maintaining efficacy and safety for the long haul.
Academic Article
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
Academic Article
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article
Unmet needs in the treatment of psoriasis.
Academic Article
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Academic Article
The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
Academic Article
In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model.
Academic Article
Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.
Academic Article
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.
Academic Article
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Academic Article
Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Academic Article
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Academic Article
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).
Academic Article
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Academic Article
Rethinking eligibility creep.
Academic Article
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study.
Search Criteria
Lymphotoxin beta